Journal ArticleOPEN ACCESS

Administration of Brincidofovir and Convalescent Plasma in a Patient with Ebola Virus Disease

Clinical Infectious Diseases (2015) 61(6) 969-973
DOI: 10.1093/cid/civ395
75Citations
Citations of this article
94Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. We present a patient with EVD who received brincidofovir and convalescent plasma. The relative contributions of supportive care, investigational therapies, and patient's immune-response on survival could not be determined. Randomized trials are needed.

Author supplied keywords

Cite

CITATION STYLE

APA

Florescu, D. F., Kalil, A. C., Hewlett, A. L., Schuh, A. J., Stroher, U., Uyeki, T. M., & Smith, P. W. (2015). Administration of Brincidofovir and Convalescent Plasma in a Patient with Ebola Virus Disease. Clinical Infectious Diseases, 61(6), 969–973. https://doi.org/10.1093/cid/civ395

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free